Renewal of license agreement between ExpreS2ion Biotechnologies and the Francis Crick Institute
On August 23 2016 ExpreS2ion Biotechnologies ApS, Horsholm, Denmark (”ExpreS2ion”) and the Francis Crick Institute, London, United Kingdom, announce that […]